# Effect of Memantine on Functional Communication in Patients With Alzheimer's Disease

> **NCT00469456** · PHASE4 · COMPLETED · sponsor: **Forest Laboratories** · enrollment: 265 (actual)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **DRUG:** Memantine
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00469456
- **Lead sponsor:** Forest Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04
- **Primary completion:** 2008-11
- **Final completion:** 2008-11
- **Target enrollment:** 265 (ACTUAL)
- **Last updated:** 2009-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00469456

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00469456, "Effect of Memantine on Functional Communication in Patients With Alzheimer's Disease". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00469456. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*